LABORATOIRES LOHMANN & RAUSCHER : revenue, balance sheet and financial ratios

LABORATOIRES LOHMANN & RAUSCHER is a French company founded 35 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in REMIREMONT (88200), this company of category PME shows in 2024 a revenue of 71.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - LABORATOIRES LOHMANN & RAUSCHER (SIREN 380236091)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue 71 445 713 € 75 111 405 € 74 257 239 € 73 818 993 € 70 065 838 € 71 678 838 € 69 401 878 € 68 849 899 € 68 537 167 €
Net income 274 749 € 110 451 € -222 835 € 1 765 408 € 1 747 342 € 1 663 685 € 1 107 388 € 403 556 € 202 008 €
EBITDA 187 153 € 444 832 € -254 759 € 3 843 749 € 3 484 031 € 3 019 553 € 1 972 519 € 2 397 894 € 1 316 800 €
Net margin 0.4% 0.1% -0.3% 2.4% 2.5% 2.3% 1.6% 0.6% 0.3%

Revenue and income statement

In 2024, LABORATOIRES LOHMANN & RAUSCHER achieves revenue of 71.4 M€. Revenue is growing positively over 9 years (CAGR: +0.5%). Slight decline of -5% vs 2023. After deducting consumption (44.8 M€), gross margin stands at 26.6 M€, i.e. a rate of 37%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 187 k€, representing 0.3% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 275 k€, i.e. 0.4% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

71 445 713 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

26 640 487 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

187 153 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

249 826 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

274 749 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

0.3%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 69%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 41%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 270.5 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 0.0% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

68.972%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

41.481%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

0.044%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

270.52

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

27.2%

Solvency indicators evolution
LABORATOIRES LOHMANN & RAUSCHER

Sector positioning

Debt ratio
68.97 2024
2022
2023
2024
Q1: 0.0
Med: 4.27
Q3: 43.96
Average +12 pts over 3 years

In 2024, the debt ratio of LABORATOIRES LOHMANN & RA... (68.97) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
41.48% 2024
2022
2023
2024
Q1: 14.64%
Med: 38.36%
Q3: 60.56%
Good +5 pts over 3 years

In 2024, the financial autonomy of LABORATOIRES LOHMANN & RA... (41.5%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
270.52 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.0 years
Q3: 1.09 years
Watch +52 pts over 3 years

In 2024, the repayment capacity of LABORATOIRES LOHMANN & RA... (270.52) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 351.56. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 71.6x. Operating income very largely covers interest expenses: high safety margin.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

351.556

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

71.622

Liquidity indicators evolution
LABORATOIRES LOHMANN & RAUSCHER

Sector positioning

Liquidity ratio
351.56 2024
2022
2023
2024
Q1: 132.74
Med: 202.27
Q3: 325.9
Excellent +33 pts over 3 years

In 2024, the liquidity ratio of LABORATOIRES LOHMANN & RA... (351.56) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
71.62x 2024
2022
2023
2024
Q1: 0.0x
Med: 0.41x
Q3: 6.25x
Excellent +50 pts over 3 years

In 2024, the interest coverage of LABORATOIRES LOHMANN & RA... (71.6x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 62 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 20 days. The gap of 42 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Inventory turnover is 32 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 90 days of revenue, i.e. 17.9 M€ to permanently finance.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

17 857 856 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

62 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

20 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

32 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

90 j

WCR and payment terms evolution
LABORATOIRES LOHMANN & RAUSCHER

Positioning of LABORATOIRES LOHMANN & RAUSCHER in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Valuation estimate

Based on 124 transactions of similar company sales (all years), the value of LABORATOIRES LOHMANN & RAUSCHER is estimated at 4 675 841 € (range 2 523 719€ - 14 231 537€). With an EBITDA of 187 153€, the sector multiple of 0.7x is applied. The price/revenue ratio is 0.21x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
124 transactions
2523k€ 4675k€ 14231k€
4 675 841 € Range: 2 523 719€ - 14 231 537€
NAF 5 all-time

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
187 153 € × 0.7x
Estimation 131 734 €
62 275€ - 479 464€
Revenue Multiple 30%
71 445 713 € × 0.21x
Estimation 15 216 108 €
8 251 335€ - 46 089 841€
Net Income Multiple 20%
274 749 € × 0.8x
Estimation 225 711 €
85 907€ - 824 267€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare LABORATOIRES LOHMANN & RAUSCHER with other companies in the same sector:

Frequently asked questions about LABORATOIRES LOHMANN & RAUSCHER

What is the revenue of LABORATOIRES LOHMANN & RAUSCHER ?

The revenue of LABORATOIRES LOHMANN & RAUSCHER in 2024 is 71.4 M€.

Is LABORATOIRES LOHMANN & RAUSCHER profitable?

Yes, LABORATOIRES LOHMANN & RAUSCHER generated a net profit of 275 k€ in 2024.

Where is the headquarters of LABORATOIRES LOHMANN & RAUSCHER ?

The headquarters of LABORATOIRES LOHMANN & RAUSCHER is located in REMIREMONT (88200), in the department Vosges.

Where to find the tax return of LABORATOIRES LOHMANN & RAUSCHER ?

The tax return of LABORATOIRES LOHMANN & RAUSCHER is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does LABORATOIRES LOHMANN & RAUSCHER operate?

LABORATOIRES LOHMANN & RAUSCHER operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.